PROSTATE ADENOCARCINOMA
Clinical trials for PROSTATE ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PROSTATE ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for PROSTATE ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New MRI-Guided radiation aims to cut prostate cancer treatment time
Disease control TerminatedThis phase 2 trial tested whether MRI-guided radiation therapy, given in fewer but higher doses, could safely treat high-risk prostate cancer while reducing side effects. The study enrolled 6 men with localized, high-risk prostate cancer who also received standard hormone therapy…
Matched conditions: PROSTATE ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Prostate cancer vaccine trial halted early – did it work?
Disease control TerminatedThis study tested a vaccine called PROSTVAC-V/F in 33 men who had their prostate removed due to cancer and were at high risk of the cancer returning. The goal was to see if the vaccine could keep cancer from coming back. The study was stopped early, so results are limited, but it…
Matched conditions: PROSTATE ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Experimental drug pacritinib tested for returning prostate cancer – but trial stopped early
Disease control TerminatedThis phase 2 trial tested the drug pacritinib in 6 men whose prostate cancer had come back after surgery or radiation, shown by rising PSA levels. The goal was to see if the drug could delay further cancer growth. However, the study was terminated early, so we have limited inform…
Matched conditions: PROSTATE ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Can a lower dose of prostate cancer drug work just as well?
Disease control TerminatedThis study looked at whether men with prostate cancer could take a lower dose of the drug abiraterone (combined with prednisone) and still control their cancer. About 50 men who had never taken abiraterone before were enrolled. The goal was to find the smallest dose that still lo…
Matched conditions: PROSTATE ADENOCARCINOMA
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Can a Plant-Based pill soothe radiation side effects in prostate cancer?
Symptom relief TerminatedThis study looked at whether a supplement called Q-Urol (made from quercetin, bromelain, rye flower pollen, and papain) could reduce prostate inflammation caused by radiation therapy in men with localized prostate cancer. Ten men who had brachytherapy (with or without other radia…
Matched conditions: PROSTATE ADENOCARCINOMA
Phase: PHASE2 • Sponsor: University of Utah • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Blood test may predict brain fog from prostate cancer treatment
Knowledge-focused TerminatedThis study aimed to see if a simple blood test could predict memory and thinking problems in men with prostate cancer receiving hormone therapy (ADT). Researchers planned to follow 32 men over time, comparing those on ADT to those not on it. The study was stopped early, so result…
Matched conditions: PROSTATE ADENOCARCINOMA
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Simple urine test could spot prostate cancer early
Knowledge-focused TerminatedThis study looked at whether DNA markers found in urine can help detect prostate cancer. Researchers collected urine and prostate fluid samples from 24 men with or suspected of having prostate cancer. The goal was to see how accurate these markers are and to understand patient op…
Matched conditions: PROSTATE ADENOCARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
New scan technique tested for prostate cancer radiation planning
Knowledge-focused TerminatedThis study tested whether combining two types of scans (PSMA-PET and MRI) can help doctors better target radiation for prostate cancer. The goal was to see if this approach is safe and possible. Only 8 people took part before the study was stopped early.
Matched conditions: PROSTATE ADENOCARCINOMA
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC